All
Accelerating skin disease research
March 6th 2017Available resources of the Center include human pathology specimens and database info on living consented patients. Techniques such as tissue imaging, gene expression analysis, T-cell receptor, sequencing studies, and CyTOF analyses are available. Visiting Scholar grants funds allow researchers to learn how to work with human tissue and how to use new techniques.
Center’s goal: Give skin disease researchers all they need
March 5th 2017A new research center makes a database of five million human pathology specimens and 22,000 living consented patients, all searchable by diagnoses, as well as cutting edge human analytic techniques available to anyone interested in carrying out translational skin disease research on human cells and tissues.
2016 studies highlight adjuvant zoster vaccine, UV protection
March 3rd 2017Important recent publications from mainstream medical journals highlight the following: Automobile side windows do not block UV radiation well; An adjuvant herpes zoster vaccine works as well in patients over 70 years old as it did in the 50-plus age group; The American Academy of Ophthalmology recommends hydroxychloroquine and chloroquine dosing based on actual, not ideal, weight.
The Toxin Head-to-Head Challenge
February 24th 2017For answers, Dermatology Times and Cosmetic Surgery Times developed an online survey for readers. The activity presented images from 6 patients who were photographed on the day of their injection and 30 days after treatment with either Xeomin® (incobotulinumtoxinA, Merz Pharmaceuticals) or Botox® (onabotulinumtoxinA, Allergan).
Nasal reconstruction after skin cancer surgery
February 16th 2017Dermatologists should consider the features of the nasal defect when weighing options for repair.Consider the desires of the patient when assessing options for both repair and treatments to mitigate post-surgical scar formation.The dermatologist must determine the choice of which procedure will likely achieve the best aesthetic outcome overall.